News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Robert F Kennedy, Jr. Announced Approval of 3 Natural Food Dyes
Robert F. Kennedy, Jr./X
May 11, 2025, 06:45

Robert F Kennedy, Jr. Announced Approval of 3 Natural Food Dyes

Robert F. Kennedy, Jr., HHS Secretary of the USA, shared on X:

“Americans don’t want to eat petroleum anymore. We’re working very well together within the agency, with CDC, NIH, US FDA, and the food industry is coming to the table and working with us to remove these harmful dyes from our food.”

Proceed to the video attached to the post.

More posts featuring Robert F Kennedy, Jr. on OncoDaily.

cancer CDC Jr. NIH OncoDaily Oncology Robert F. Kennedy US FDA
Special Coverage
Blog
Jun 1, 2025, 04:58
Yan Leyfman: Excited to Present Research on GLP-1 Receptor Agonists at ASCO 2025
Blog
Jun 1, 2025, 04:53
Erika Hamilton: Highlights from Me at Day 2 of ASCO25
Oncolibrary
Jun 1, 2025, 04:52
BREAKWATER Trial: New Standard for BRAF V600E Metastatic Colorectal Cancer at ASCO 2025
Blog
Jun 1, 2025, 04:47
National Cancer Institute of Kenya - Major Breakthrough in Breast Cancer Treatment Costs in Kenya
Blog
Jun 1, 2025, 04:39
Guillermo Chantada: SIOP and ISOO Sign Agreement to Advance Retinoblastoma Care Globally
Opinion
Jun 1, 2025, 04:14
Every Trial Gives Hope: Tian Zhang Shared Reflections Ahead of ASCO 2025
Insight
Jun 1, 2025, 04:10
Paolo Tarantino: Impressive Phase 2 Data with the Trop2 ADC Sac-TMT for 1L mTNBC at ASCO 2025
Insight
Jun 1, 2025, 04:01
Kunal Jobanputra: Our Abstract on Metastatic Pancreatic Cancer in Western India Published in JCO
Oncolibrary
Jun 1, 2025, 03:54
POLCAGB Results at ASCO 2025: Concurrent Chemoradiation Plus Chemotherapy Improves Survival and Resection Outcomes in Locally Advanced Gallbladder Cancer
Oncolibrary
Jun 1, 2025, 03:54
INAVO120 Trial Final OS Analysis: INAVO Plus Palbociclib and Fulvestrant Improves Survival in PIK3CA-Mutated HR+/HER2– Advanced Breast Cancer
Career
Jun 1, 2025, 03:45
Enrique Soto: Honored to Receive the Conquer Cancer, the ASCO Foundation Advanced Clinical Research Award
Oncolibrary
Jun 1, 2025, 03:12
KEYNOTE-630 Phase 3 Trial at ASCO 2025: Adjuvant Pembrolizumab Does Not Significantly Improve Outcomes in High-Risk Resected Cutaneous Squamous Cell Carcinoma